Literature DB >> 19763661

Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy.

Gjin Ndrepepa1, Dritan Keta, Stefanie Schulz, Robert A Byrne, Julinda Mehilli, Jürgen Pache, Melchior Seyfarth, Albert Schömig, Adnan Kastrati.   

Abstract

PURPOSE: The prognostic impact of low-flow reperfusion after percutaneous coronary intervention (PCI) in patients with ST-segment elevation acute myocardial infarction (STEMI) is unknown. The aim of the study was to investigate the impact of low-flow reperfusion after PCI in patients with STEMI.
METHODS: This study included 1,761 patients with STEMI with a baseline thrombolysis in myocardial infarction (TIMI) flow grade 0 and no collateral circulation to the infarcted region before primary PCI. The primary outcome was 1-year mortality.
RESULTS: At the end of PCI procedure there were 115 patients with post-PCI TIMI flow grade 0; 57 patients with TIMI flow grade 1; 218 patients with TIMI flow grade 2; and 1,371 patients with TIMI flow grade 3. At 1 year there were 36 deaths in patients with TIMI grade 0; 28 deaths in patients with TIMI grade 1; 42 deaths in patients with TIMI grade 2; and 162 deaths in patients with TIMI grade 3 [estimates of mortality 32.6, 49.1, 19.6 and 12.1%, respectively; odds ratio (OR) = 1.76, 95% CI 1.08-2.86, P = 0.02, for TIMI flow grade 1 vs. TIMI flow grade 0]. The Cox proportional hazards model identified post-PCI TIMI flow grade as an independent predictor of 1-year mortality [hazard ratio (HR) = 1.99, 95% CI 1.17-3.28; P = 0.01 for TIMI flow grade 1 vs. TIMI flow grade 0].
CONCLUSIONS: Patients with STEMI with totally occluded infarct-related arteries and no collateral blood flow to the infarcted region show a greater mortality with post-PCI TIMI flow grade 1 than TIMI flow grade 0.

Entities:  

Mesh:

Year:  2009        PMID: 19763661     DOI: 10.1007/s00392-009-0070-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  28 in total

1.  Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia.

Authors:  C Duilio; G Ambrosio; P Kuppusamy; A DiPaula; L C Becker; J L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-06       Impact factor: 4.733

2.  Low flow after global ischemia to improve postischemic myocardial function and bioenergetics.

Authors:  Paul F Klawitter; Holt N Murray; Thomas L Clanton; Brian S Palmer; Mark G Angelos
Journal:  Crit Care Med       Date:  2002-11       Impact factor: 7.598

3.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man.

Authors:  H Sandler; H T Dodge
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

4.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

5.  Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction.

Authors:  J L Anderson; L A Karagounis; R M Califf
Journal:  Am J Cardiol       Date:  1996-07-01       Impact factor: 2.778

6.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

7.  Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group.

Authors:  T Lenderink; M L Simoons; G A Van Es; F Van de Werf; M Verstraete; A E Arnold
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Myocardial contractile function during postischemic low-flow reperfusion: critical thresholds of NADH and O2 delivery.

Authors:  Jason D Stoner; Mark G Angelos; Thomas L Clanton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-09-04       Impact factor: 4.733

10.  Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes.

Authors:  M Tanaka; H Ito; S Adachi; H Akimoto; T Nishikawa; T Kasajima; F Marumo; M Hiroe
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367

View more
  6 in total

1.  One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial.

Authors:  Stefanie Schulz; K Anette Birkmeier; Gjin Ndrepepa; Werner Moshage; Franz Dotzer; Kurt Huber; Josef Dirschinger; Melchior Seyfarth; Albert Schömig; Adnan Kastrati; Julinda Mehilli
Journal:  Clin Res Cardiol       Date:  2010-06-27       Impact factor: 5.460

2.  Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: an analysis over an 8-year period in a tertiary care centre.

Authors:  Ulrike M Müller; Ingo Eitel; Kristina Eckrich; Sandra Erbs; Axel Linke; Sven Möbius-Winkler; Meinhard Mende; Gerhard C Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2010-10-24       Impact factor: 5.460

3.  Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials.

Authors:  Alban Dibra; Klaus Tiroch; Stefanie Schulz; Henning Kelbaek; Christian Spaulding; Gerrit J Laarman; Marco Valgimigli; Emilio Di Lorenzo; Christoph Kaiser; Ilkka Tierala; Julinda Mehilli; Gianluca Campo; Leif Thuesen; Maarten A Vink; Martin J Schalij; Roberto Violini; Albert Schömig; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2010-03-11       Impact factor: 5.460

4.  TNF-α, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention.

Authors:  Eva S Kehmeier; Wolfgang Lepper; Martina Kropp; Christian Heiss; Ulrike Hendgen-Cotta; Jan Balzer; Mirja Neizel; Christian Meyer; Marc W Merx; Pablo E Verde; Christian Ohmann; Gerd Heusch; Malte Kelm; Tienush Rassaf
Journal:  Clin Res Cardiol       Date:  2012-05-06       Impact factor: 5.460

5.  Microvascular Obstruction Evaluation Using Cardiovascular Magnetic Resonance (CMR) in ST-Elevated Myocardial Infarction (STEMI) Patients.

Authors:  Dorota Piotrowska-Kownacka; Łukasz Kownacki; Janusz Kochman; Agnieszka Kołodzińska; Małgorzata Kobylecka; Leszek Królicki
Journal:  Pol J Radiol       Date:  2015-12-13

6.  MicroRNA-126 and VEGF enhance the function of endothelial progenitor cells in acute myocardial infarction.

Authors:  Ying Zhang; Yi Xu; Ke Zhou; Guoying Kao; Jun Xiao
Journal:  Exp Ther Med       Date:  2021-12-14       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.